NOVAVAX INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Novavax Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Novavax Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $1.13B, a 10.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.13B +$109M +10.7% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $1.02B +$4.79M +0.47% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $1.02B +$511M +101% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $505M +$139M +38% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $366M +$28.3M +8.37% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $338M +$37.7M +12.6% Dec 31, 2018 10-K 2020-03-11
Q4 2017 $300M -$54.7M -15.4% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $355M +$118M +49.7% Dec 31, 2016 10-K 2018-03-14
Q4 2015 $237M +$63.9M +37% Dec 31, 2015 10-K 2017-02-27
Q4 2014 $173M +$30.4M +21.3% Dec 31, 2014 10-K 2016-02-29
Q4 2013 $143M +$7.12M +5.26% Dec 31, 2013 10-K 2015-02-27
Q4 2012 $135M +$9.4M +7.46% Dec 31, 2012 10-K 2014-03-12
Q4 2011 $126M Dec 31, 2011 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.